🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zachary Maben

Pfizer (United States)

ORCID: 0000-0002-3197-8437

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A broadly applicable approach to T cell epitope identification: Application to improving tumor associated epitopes and identifying epitopes in complex pathogens”.

A broadly applicable approach to T cell epitope identification: Application to improving tumor associated epitopes and identifying epitopes in complex pathogens

UNC Libraries(2020)10.17615/d8cp-t149

N/A

0DataRank · unranked

0 citations

Lucinda Hensley, Zachary Maben, Michael D. Valentino, Edith M. Lord, John G. Frelinger +5 more

Conformational dynamics linked to domain closure and substrate binding explain the ERAP1 allosteric regulation mechanism

Nature Communications(2021)10.1038/s41467-021-25564-w

N/A

0DataRank · unranked

43 citations

Richa Arya, Dimitris Georgiadis, Efstratios Stratikos, Lawrence J. Stern, Zachary Maben

Phenylsulfamoyl Benzoic Acid Inhibitor of ERAP2 with a Novel Mode of Inhibition

ACS Chemical Biology(2022)10.1021/acschembio.2c00093

N/A

0DataRank · unranked

5 citations

Zachary Maben, Digamber Rane, Akbar Ali, Lawrence J. Stern, Richa Arya